The store will not work correctly when cookies are disabled.
7,8-dimethyl-2-((pyrimidin-2-ylthio)methyl)quinazolin-4(3H)-one
ID: ALA5186007
PubChem CID: 137332078
Max Phase: Preclinical
Molecular Formula: C15H14N4OS
Molecular Weight: 298.37
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc2c(=O)[nH]c(CSc3ncccn3)nc2c1C
Standard InChI: InChI=1S/C15H14N4OS/c1-9-4-5-11-13(10(9)2)18-12(19-14(11)20)8-21-15-16-6-3-7-17-15/h3-7H,8H2,1-2H3,(H,18,19,20)
Standard InChI Key: NHFMMPLQVIZDPX-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
-2.4986 1.2369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7840 1.6492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0721 1.2374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0721 0.4121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7822 0.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4986 0.4084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3575 1.6499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3570 1.2373 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3570 0.4121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3575 -0.0002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3575 2.4751 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0717 -0.0002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0717 -0.8256 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.7863 -1.2381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7822 -0.8247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5011 -0.8258 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2133 -1.2378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2133 -2.0632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5029 -2.4751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7863 -2.0669 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.2133 -0.0040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
8 7 1 0
9 8 1 0
10 9 2 0
4 10 1 0
7 11 2 0
9 12 1 0
12 13 1 0
14 13 1 0
5 15 1 0
16 14 2 0
17 16 1 0
18 17 2 0
19 18 1 0
20 19 2 0
14 20 1 0
6 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 298.37 | Molecular Weight (Monoisotopic): 298.0888 | AlogP: 2.62 | #Rotatable Bonds: 3 |
Polar Surface Area: 71.53 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.78 | CX Basic pKa: 4.73 | CX LogP: 2.55 | CX LogD: 2.55 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.59 | Np Likeness Score: -1.80 |
References
1. Nizi MG, Maksimainen MM, Lehtiö L, Tabarrini O.. (2022) Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules., 65 (11.0): [PMID:35608571] [10.1021/acs.jmedchem.2c00281] |